NEW PHARMACEUTICAL USE

HIF-1 and HIF-2 inhibitors

Fusion protein comprising a Pab1 element and an eIF4G element and use of the fusion protein for improving protein synthesis

Anti-PVRIG antibodies and methods of use

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and nanoparticle formulations thereof

PEPTIDES OF USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA

Peptides and uses thereof for treating cancer

Targeted delivery system and methods of use therefor

Peptoid, and its preparation method and use

SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS

Drug-conjugates, conjugation methods, and uses thereof

NOVEL LINKER, PREPARATION METHOD, AND APPLICATION THEREOF

Peptides and combination of peptides for use in immunotherapy against various tumors

Solution phase routes for Wnt hexapeptides

ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF

Method of treating melanocortin-4 receptor pathway-associated disorders

Bone-targeting antibodies

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY

Peptide and use therefor

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

Peptides for binding to CD44v6 and use thereof

Peptide bound to PD-L1 and use thereof

Cell penetrating peptide

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Compositions comprising circular polyribonucleotides and uses thereof

N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto

Sensitizer-peptide conjugate

Methods and products for in vivo enzyme profiling

PEPTIDES DERIVED FROM PRORELAXIN H1 (RLN1)

VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD

Inhibitors of blood coagulation factor XIII

PEPTIDES DERIVED FROM ACTIN-LIKE PROTEIN 8 (ACTL8)

ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates

SOLUBILITY ENHANCING PROTEIN EXPRESSION SYSTEMS

PEPTIDES

MULTIVALENT LIGAND-LIPID CONSTRUCTS

Peptide synthesis method

ACCUMULATIVE BORON 10 MEDICINE FOR BORON NEUTRON CAPTURE THERAPY FOR SELECTIVELY OR LOCALLY TARGETING TUMOR TISSUES IN SHORT TIME

A*03 restricted peptides for use in immunotherapy against cancers and related methods

CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES

Manufacture of degarelix

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

TRPV3 agonists for the treatment of skin conditions

PEPTIDE-COMPRISING ELECTRODE

Membrane probes for expansion microscopy

PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME

Inhibitors of metastasis

Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules

MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS

A*03 restricted peptides for use in immunotherapy against cancers and related methods

A*03 restricted peptides for use in immunotherapy against cancers and related methods

Peptides for dry eye disease

Adiponectin peptidomimetics for treating ocular disorders

POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

PEPTIDES

PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF

PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF

CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF

Co-assembly peptides, nanostructures, and methods of making and using the same

NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS

RESPIRATORY SYNCYTIAL VIRUS VACCINE

CD200 inhibitors and methods of use thereof

CEACAM based antibacterial agents

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Goggle imaging systems and methods

Engineered cascade components and cascade complexes

Methods and compositions useful for inhibiting growth of certain bacteria

WT1 CANCER ANTIGEN PEPTIDES AND PEPTIDE CONJUGATES COMPRISING THE PEPTIDES

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Compositions and methods for reducing ice crystal formation

B*44 restricted peptides for use in immunotherapy against cancers and related methods

Process for the preparation of Degarelix acetate and Degarelix acetate-mannitol premix

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

Phage-peptide constructs for stimulating an immune response against CD47

Bioactive peptides having detrimental effects on pest slugs

CRISPR-BASED GENOME MODIFICATION AND REGULATION

Modulation of structured polypeptide specificity

Peptide showing melanogenesis promoting activity and use thereof

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES

IMPROVED PEPTIDE PHARMACEUTICALS

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

Peptides Having Anti-Inflammatory Properties

Manufacture of Degarelix

Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials

Modified peptides and associated methods of use

ANTIFOLATE CONJUGATES FOR TREATING INFLAMMATION

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptide-compound cyclization method

PEPTIDES FROM PIWIL1

Cell-permeable stapled peptide modules for cellular delivery

Peptide

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

PEPTIDES

PEPTIDES

Affinity ligands for antibody Fc region

Inhibitors of β integrin-G protein α subunit binding interactions

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

ANDRIAS DAVIDIANUS CARTILAGE PREPARATION

Methods and systems for solid phase peptide synthesis

PSMA-targeted NIR dyes and their uses

Food Protein-Derived Peptides as Bitter Taste Blockers

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases

ENGINEERED VEGF VARIANTS FOR RETINAL NEUROPROTECTION, PROMOTION OF AXON GROWTH AND AXON REGENERATION

OLIGOPEPTIDE HAVING DENGUE VIRUS REPLICATION INHIBITION FUNCTION AND APPLICATION THEREOF

Peptides for treating telomere dysfunction-associated diseases and uses thereof

MICROMOLECULE POLYPEPTIDE AND USE THEREOF

Cyclic peptidyl inhibitors of CAL-PDZ binding domain

PEPTIDE NANOFIBERS

Polypeptides having anti-senescent effects and uses thereof

Cancer Antigen Peptide

Compositions comprising cyclic peptides derived from an A-beta peptide

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

PEPTIDES

Peptides and compositions for use in cosmetics and medicine

IL-17F-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

Degradable polyethylene glycol conjugate

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

ANTI-FOULING PAINTS AND COATINGS

PEPTIDES DERIVED FROM P ANTIGEN FAMILY MEMBER 2 (PAGE2)

Albicidin derivatives, their use and synthesis

PEPTIDES

PEPTIDES

METHOD OF GENERATING INTERACTING PEPTIDES

Manganese-based chelate conjugates for molecular MR imaging

Oligonucleotide analogues targeting human LMNA

ANTI-AGGRUS MONOCLONAL ANTIBODY, DOMAIN IN AGGRUS WHICH IS REQUIRED FOR BINDING TO CLEC-2, AND METHOD FOR SCREENING FOR AGGRUS-CLEC-2 BINDING INHIBITOR

Biomimetic peptides derived from biological source and their uses in retarding aging and improving skin

Arid5a peptide inhibitors

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Engineered cascade components and cascade complexes

Peptide therapies for reduction of macular thickening

Bone fracture repair by targeting of agents that promote bone healing

Antimicrobial compositions and methods of use thereof

Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug-and Extensively Drug-Resistant Pseudomonas Aeruginosa

Compositions and methods for inhibiting lactate dehydrogenase a activity

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

Chimeric polypeptides and uses thereof

PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE

Peptide conjugates

Compositions and methods for inhibiting CD279 interactions

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers

METHOD FOR DETERMINING ELIGIBILITY OF BRAIN TUMOR PATIENT FOR TAILOR-MADE TYPE PEPTIDE VACCINE AGENT

FUSION PROTEIN

Immunogenic WT-1 peptides and methods of use thereof

PEPTIDE COMPOSITIONS AND RELATED METHODS

DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES

NOVEL METHODS FOR DISPLAYING CYCLIC PEPTIDES ON BACTERIOPHAGE PARTICLES

PVRIG polypeptides and methods of treatment

MODIFIED BISPECIFIC T CELL RECEPTORS

Cell penetrating peptides and methods of making and using thereof

CBX8 chromdomain inhibitors and the uses thereof

USE OF EXCITATORY NERVE INJURY-RELATED POLYPEPTIDE IN PREVENTING, ALLEVIATING OR TREATING PAIN

Chloride salt of TAT-NR2B9C

Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof

One-bead-two-compound macrocyclic library and methods of preparation and use

PEPTIDE CONSTRUCTS AND METHODS FOR ENHANCEMENT OF INTERFERON PRODUCTION

Peptide having cytoprotective effect against environmental pollutant and use thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

FRAGMENTS OF P97 AND USES THEREOF

System and method for identification and characterization of transglutaminase species

Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)

Tumor-specific polypeptide and use thereof

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

CHARACTERIZATION OF DOMAIN-SPECIFIC CHARGE VARIANTS OF ANTIBODIES

Methods and compositions for preventing influenza infection

Vault complexes for cytokine delivery

COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME

Fragment synthesis of substituted cyclic peptides

METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE

TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

ANTI-FOULING PAINTS AND COATINGS

Peptide inhibitors of insulin-degrading enzyme

PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF

Dual mass spectrometry-cleavable crosslinking reagents for protein-protein interactions

PEPTIDE COMPOSITIONS AND RELATED METHODS

Immunogenic peptides specific to BCMA and TACI antigens

N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same

Orally active, cell-penetrating homing peptide and methods using same

Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors

Agents targeting inhibitor of apoptosis proteins

Immunotherapy against neuronal and brain tumors

B*44 restricted peptides for use in immunotherapy against cancers and related methods

B*44 restricted peptides for use in immunotherapy against cancers and related methods

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Compositions and methods for managing respiratory conditions

Crystobactamides

PEPTIDE AND METHOD FOR REDUCING THE PHOSPHATE REQUIREMENT AND EXCRETION FROM FARM ANIMALS

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

Drug Delivery Enhancement Agents

Epitope-targeted peptide immunostimulants

A*03 restricted peptides for use in immunotherapy against cancers and related methods

Method of treating with a peptide

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

MALIGNANT TUMOR TARGET PEPTIDE

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Cyclic peroxides as prodrugs for selective delivery of agents

METHODS OF TREATING CANCER USING COMPOUNDS CONTAINING A VASCULAR DISRUPTING AGENT

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Method of facilitating the bindings between keratinocytes

Thioredoxin 1 epitope, encoding nucleic acid and methods of binding a monoclonal antibody

Composition for delivery of genetic material

Peptides and combination of peptides for use in immunotherapy against various tumors

Stapled intracellular-targeting antimicrobial peptides to treat infection

α4α7 peptide monomer and dimer antagonists

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

DEPDC1-derived peptide and vaccine containing same

Composite polypeptide having a metal binding motif and molecular construct comprising the same

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

Crosslinked hydrogel compositions for regulating states of encapsulated cancer cells

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

Recombinant RSV G proteins and their use

Substance P analog having progenitor cell or stem cell recruiting activity and method for progenitor cell or stem cell recruiting using the same

Synthetic peptides, pharmaceutical compositions comprising the same, and uses thereof in treating thromboembolism-related diseases

POLYPEPTIDE WITH FUNCTION OF INHIBITING ABETA 42 PROTEIN AGGREGATION AND USE THEREOF, AND GENE ENCODING THE POLYPEPTIDE

SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

COMPOSITIONS AND METHODS FOR REDUCING IMMUNE RESPONSES AGAINST CHIMERIC ANTIGEN RECEPTORS

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IL-2Rgamma binding compounds

IL-2RBETA binding compounds

METHOD FOR PRODUCING PEPTIDE COMPOUND

IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

A*03 restricted peptides for use in immunotherapy against cancers and related methods

Method of treating with a peptide

Treatments for Gastrointestinal Disorders

Branched peptides for enzymatic assembly and mitochondria drug delivery

Chemiluminescent probes for imaging/detection of proteases

Engineered cascade components and cascade complexes

Proximity-based sortase-mediated protein purification and ligation

Desmoglein 2 (DSG2) binding proteins and uses therefor

Peptide for inhibiting angiogenesis and use thereof

Peptide compositions and methods of use thereof

Interleukin 15 fusion protein for tumor targeting therapy

Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses

SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE

Peptides and pharmaceutical compositions for treating eye diseases

Gene expression inhibitors

Polymer agonists of mu opioid receptors

Compositions that target tumor-associated macrophages and methods of use therefor

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)

COMPOSITIONS FOR DELIVERY TO AND TREATMENT OF ATHEROSCLEROTIC PLAQUES

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers